Stock Events

Stock Events

Azitra 

$0.8415
63
+$0.07+9.39% 17:36 Today

Statistics

Day High
0.8537
Day Low
0.7404
52W High
5.32
52W Low
0.52
Volume
8,367,517
Avg. Volume
-
Mkt Cap
5.1M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 17Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.7
-1.14
-0.57
-0.01
Expected EPS
-0.2
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2022
2023
2024
2025
0Revenue
-10.96MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AZTR. It's not an investment recommendation.
NVIDIA
6
NVDA
YieldMax MSTR Option Income Strategy
6
MSTY
YieldMax COIN Option Income Strategy
6
CONY
YieldMax TSLA Option Income Strategy
5
TSLY

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Krystal Biotech
KRYS
Mkt Cap9.84B
Krystal Biotech, Inc. focuses on gene therapies for dermatological diseases, directly competing with Azitra's skin condition treatments.
Abeona Therapeutics
ABEO
Mkt Cap248.75M
Abeona Therapeutics Inc. works on developing gene and cell therapies for skin diseases and other serious conditions, overlapping with Azitra's focus areas.
Ultragenyx Pharmaceutical
RARE
Mkt Cap1.59B
Ultragenyx Pharmaceutical Inc. develops therapies for rare and ultra-rare diseases, including skin disorders, competing in the same niche as Azitra.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical Inc. offers therapies for rare genetic diseases, some of which involve skin symptoms, indirectly competing with Azitra.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. has a broad portfolio including dermatology, competing in the market for skin disease treatments.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. has a diverse biotechnological portfolio, including treatments for skin conditions, making it a competitor in the biotech space.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc., with its extensive range of healthcare products, including treatments for skin conditions, competes in various therapeutic areas with Azitra.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson operates in multiple healthcare sectors, including skin health, making it a broad competitor to Azitra in the healthcare market.

About

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Show More
CEO
Francisco D. Salva
Employees
13
Country
United States
ISIN
US05479L4014

Listings

XASE
US
AZTR
BOATS
BOATS
AZTR.BOATS

0 Comments

Share your thoughts

FAQs

What is Azitra stock price today?▼
The current price of AZTR is $0.84 USD — it has increased by +9.39% in the past 24 hours. Watch Azitra stock price performance more closely on the chart.
What is Azitra stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Azitra stocks are traded under the ticker AZTR.
Is Azitra stock price growing?▼
AZTR stock has fallen by -46.59% compared to the previous week, the month change is a -38.1% fall, over the last year Azitra has showed a -84.38% decrease.
What is Azitra market cap?▼
Today Azitra has the market capitalization of 5.1M
When is the next Azitra earnings date?▼
Azitra is going to release the next earnings report on November 17, 2026.
What were Azitra earnings last quarter?▼
AZTR earnings for the last quarter are -1.7 USD per share, whereas the estimation was -1.15 USD resulting in a -47.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Azitra revenue for the last year?▼
Azitra revenue for the last year amounts to 0 USD.
What is Azitra net income for the last year?▼
AZTR net income for the last year is -10.96M USD.
How many employees does Azitra have?▼
As of November 2, 2026, the company has 13 employees.
In which sector is Azitra located?▼
Azitra operates in the Health & Wellness sector.
When did Azitra complete a stock split?▼
The last stock split for Azitra was on October 26, 2026 with a ratio of 1:10.
Where is Azitra headquartered?▼
Azitra is headquartered in BRANFORD, United States.